Introducing the Modern Pathology Editor’s Academy Program

USCAP and Modern Pathology are in the process of creating the Editor’s Academy, a program designed to provide junior faculty members (i.e., instructors and assistant professors) with peer review training and experience under the mentorship of distinguished leaders in the field.

Modern Pathology is a high-impact international journal owned by the United States and Canadian Academy of Pathology (USCAP), the leader in in continuing medical education for pathologists in North America. The journal aims to provide an authoritative platform for publishing the highest quality clinical and translational research studies in pathology.

The journal is seeking applicants interested in learning manuscript review. 

Qualifications:

  • MD or equivalent is required
  • Applicant must hold a faculty appointment at the level of instructor or assistant professor at an academic institution
  • Membership in USCAP is required
  • Applicants must have a demonstrated record of academic productivity with at least three abstract submissions to the USCAP annual meeting for the past three years and 10 publications, at least five of which are first author

Application Process

Applicants should submit the following materials via the application form (https://uscap.org/2025-mpap-application).

  • A current CV, including a publication list
  • An explanation of why you are interested in the program (maximum 250 words)
  • A short description of prior experience in scientific reviewing (maximum 250 words)
  • An abstract from one of your publications

Benefits

  • Training in various aspects of the editorial processes with journal editors, building skills as reviewer
  • Opportunities to network with Modern Pathology’s prestigious editors
  • Recognition on the journal masthead and website

Expectations:

  • Communicate effectively with the journal editorial office and editors
  • Review manuscripts in a timely manner
  • The term is for two years

Program Timeline

October 15, 2025–November 30, 2025 Application open
December 15, 2025 Applicants notified of decision
January 2026–December 2027 Participants review manuscripts

 

Selections will be made by a committee composed of Modern Pathology editors

Questions about the program or application? Email: EdAcad@uscap.org

MENTORS

Mahul Amin, MD
University of Tennessee Health Sciences
Memphis, Tennessee, United States

Henry D Appelman, MD
University of Michigan
Ann Arbor, Michigan, United States

Sylvia Asa, MD, PhD
University Hospital Cleveland Medical Center
Cleveland, Ohio, United States

Steven D Billings, MD
Cleveland Clinic
Cleveland, Ohio, United States

Julia Bridge, MD
The Translational Genomics Research Institute
Phoenix, Arizona, United States

Klaus Busam, MD
Memorial Sloan Kettering Cancer Center
New York, New York, United States

Amy Chadburn, MD
Weill Cornell Medical College
New York, New York, United States

Alcides Chaux, MD
Universidad del Norte
Asuncion, Paraguay

Sonika Dahiya, MD
Washington University School of Medicine
St Louis, Missouri, United States

Meera Hameed, MD
Memorial Sloan Kettering Cancer Center
New York, New York, United States

Jason L Hornick, MD, PhD
Brigham and Women’s Hospital
Boston, Massachusetts, United States

Ralph Hruban, MD
Johns Hopkins Medical Institute
Baltimore, Maryland, United States

 

Pei Hui, MD, PhD
Yale University School of Medicine
New Haven, Connecticut, United States

Philip Ip, MBChB
The University of Hong Kong
Hong Kong SAR, China

Jose Jessurun, MD
Weill Cornell Medical College
New York, New York, United States

Leite Katia, MD, PhD
University of Sao Paulo Medical School
Sao Paulo, Brazil

Alexander J Lazar, MD, PhD
University of Texas MD Anderson Cancer Center
Houston, Texas, United States

Rohit Mehra, MD
University of Michigan
Ann Arbor, Michigan, United States

Murray B Resnick, MD, PhD
Brown University
Providence, Rhode Island, United States

Stuart J Schnitt, MD
Brigham and Women’s Hospital
Boston, Massachusetts, United States

William D Travis, MD
Memorial Sloan Kettering Cancer Center
New York, New York, United States

Sarah O Vargas, MD
Boston Children’s Hospital
Boston, Massachusetts, United States

Sean Williamson, MD
Cleveland Clinic
Cleveland, Ohio, United States